Financial Data and Key Metrics Changes - Revenue for the first quarter of 2025 increased to $1,577,000, up from $1,114,000 in the first quarter of 2024, representing a 42% increase driven by heightened demand for bit solutions, mobile systems, and IHP corporate services [11] - Product-based revenues totaled $1,000,000 in Q1 2025, reflecting a 35% growth compared to Q1 2024, while service revenues generated $577,000, a 56% increase from the same prior year period [11] - Gross margin as a percentage of sales for the three months ended March 31, 2025, was 60.4%, compared to 60.2% in the same prior year period [12] - Operating loss for the quarter was approximately $754,000, an improvement from the operating loss of $1,226,000 in the same quarter last year [12] - Net loss was approximately $256,000 or $0.01 per share, compared to $1,310,000 or 7% loss per share in the prior year [12] Business Line Data and Key Metrics Changes - BIT solution sales reached approximately $300,000, marking nearly a 200% increase from just over $100,000 in the first quarter of last year [12] - The company experienced a 169% surge in BIT solution sales year-to-date compared to the same period last year [6] - The increase in sales was attributed to new service offerings launched in February 2024 and collaborations with partners [6][8] Market Data and Key Metrics Changes - The company welcomed several new customers, including a new division of the US Army and a children's hospital in Philadelphia, indicating expansion into new markets [8] - The open sales log increased from approximately $877,000 at the end of 2024 to $1,600,000 by the end of Q1 2025, reflecting growing demand [10] Company Strategy and Development Direction - The company is focused on expanding customer outreach through targeted marketing initiatives and strategic partnerships to sustain growth in consumable BIT solution sales [7] - There is a commitment to educating the market on the importance of protective disinfection through the SteraMist Pro certified program [7] - The company anticipates a positive trend in sales throughout the year for BIT solutions, equipment services, and custom designs [14] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about sustaining sales momentum and highlighted significant progress made in Q1 2025 [5][24] - The company is actively negotiating $2,000,000 among five potential orders for custom engineered systems, indicating a strong pipeline for future growth [17] - Management noted that they are not experiencing problems with international sales due to tariffs and expect positive developments in government-related sales [28][29] Other Important Information - The company is enhancing its sales infrastructure by establishing new distribution channels and recruiting independent representatives [21] - There is ongoing work to finalize a new partnership that could make a customer the highest service customer for the IHP corporate service deployment [22] Q&A Session Summary Question: Do you have any financial goals for the year 2025 that you can share with us? - Management is confident that 2025 will be a great year and expects to improve on last year's numbers [26] Question: Do you anticipate any effects from the tariffs trade policy? - Management indicated that they are not having problems with international sales due to tariffs and are hopeful for a resolution soon [28] Question: Do you anticipate that government budget cuts will pose significant problems for TOMI? - Management believes that there will be an increase in government demand for their products, particularly in critical testing and studies [29] Question: Any new developments on food safety? - Management reported a surge in interest and requests for quotes related to food safety, indicating a growing market [31] Question: Any updates on SteraMist for prevention of bird flu transmission? - Management noted that there is increased interest in using their product for disinfection related to bird flu, although no significant developments were reported [33] Question: Any new developments on Ceramist as an ethylene oxide replacement? - Management confirmed ongoing negotiations with companies looking to replace ethylene oxide with Ceramist [34] Question: Was the order for treating pacemakers used in replacement of ethylene oxide? - Management clarified that the order was not a replacement but helped develop a new protocol for use [36] Question: Have you developed new ways to educate the market about your products? - Management launched the SteraMist Pro certified program to educate their entire customer base and distributors [38]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 increased to $1,577,000, up from $1,114,000 in Q1 2024, representing a 42% increase driven by heightened demand for bit solutions and mobile systems [11] - Product-based revenues totaled $1,000,000 in Q1 2025, reflecting a 35% growth compared to Q1 2024 [11] - Service revenues generated $577,000, a 56% increase from the same prior year period [11] - BIT solution sales reached approximately $300,000, marking nearly a 200% increase from just over $100,000 in Q1 2024 [12] - Operating loss for the quarter was approximately $754,000, an improvement from the operating loss of $1,226,000 in the same quarter last year [12] - Net loss was approximately $256,000 or $0.01 per share compared to $1,310,000 or 7% loss per share in the prior year [12] - Cash and cash equivalents stood at approximately $674,000, with working capital of $3,800,000 [13] Business Line Data and Key Metrics Changes - Total sales in February 2025 saw a 42% increase compared to February 2024, with a 21% increase in April 2025 compared to April 2024 [6] - Year-to-date, there was a 169% surge in bit solution sales compared to the same period last year [6] - The company welcomed several new customers, including a division of the US Army and a children's hospital, indicating expansion in various sectors [8] Market Data and Key Metrics Changes - The company reported an increase in open sales log from approximately $877,000 at the end of 2024 to $1,600,000 by the end of Q1 2025 [10] - The IHP corporate service deployment pipeline currently stands at $1,000,000 in open proposals for 2025 [22] Company Strategy and Development Direction - The company is focused on expanding its product line and distribution strategy, with new service offerings launched in 2024 [5] - There is a commitment to educating the market on the importance of protective disinfection through the SteraMist Pro certified program [7] - The company aims to enhance its sales infrastructure by establishing new distribution channels and recruiting qualified business developers [21] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about sustaining sales momentum and anticipated a positive trend in sales throughout the year [14] - The company is encouraged by significant progress made in Q1 2025, showcasing the effectiveness of its strategies and product offerings [23] - Management noted that they are not experiencing significant problems due to government budget cuts and expect increased demand from government sectors [28] Other Important Information - The company is actively seeking strong global partners and is focused on rebuilding brand presence in various international markets [21] - The partnership with AlgaFeed has opened a new aquaculture market for SteriMist IHP [8] Q&A Session Summary Question: Do you have any financial goals for the year 2025? - Management is confident that 2025 will be a great year and expects to improve on last year's numbers [25] Question: Do you anticipate any effects from the tariffs trade policy? - Management indicated that they have had minor issues with tariffs but are not experiencing significant problems with international sales [26][27] Question: Do you anticipate significant problems due to government budget cuts? - Management believes there will be an increase in demand from government sectors that utilize their products [28] Question: Any new developments on food safety? - Management reported a surge in interest and requests related to food safety, indicating a growing market [30] Question: Any updates on SteraMist for prevention of bird flu transmission? - Management noted that there is increased interest in using their products for bird flu disinfection, but no significant developments have materialized recently [31][32] Question: Any new developments on Ceramist as an ethylene oxide replacement? - Management confirmed ongoing negotiations with companies looking to replace ethylene oxide with Ceramist [33] Question: Was the order for treating pacemakers used in replacement of ethylene oxide? - The order was not a replacement but helped develop a new protocol for the medical device manufacturer [34][35] Question: Have any new ways been developed to educate the market? - The SteraMist Pro certified program was launched to educate the market and improve product usage [37][38]